page image

Epilepsie

Referenties

  1. http://epilepsienukanhetbeter.nl/index2.html, september 2011.
  2. http://epilepsie.nl/informatie/, september 2011.
  3. http://epilepsie.nl/leven_met_epilepsie/latere_leeftijd, september 2011.
  4. http://epilepsie.nl/informatie/soorten_aanvallen, september 2011.
  5. National Institute of Neurological disorders and stroke, 2006.
  6. Halliwell B: Role of free radicals in the neurodegenerativee diseases:Therapeutic implications for antioxidant treatment; Drugs Aging 18(19):685-716, 2001. PMID 11599635.
  7. Kaufman KR, Sachdeo RC: Caffeinated beverages and decreased seizure control; Seizure 12(7):519-521, 2003. PMID 12967583.
  8. Zaidi SM, Banu N: Antioxidant potential of vitamins A, E, C in modulating oxidative stress in rat brain; Clin Chim Acta 340(1-2):229-233, 2004. PMID 14734217.
  9. Frucht MM et al: Distribution of seizure precipitants among epilepsy syndromes; Epilepsia 41(12):1534-1539, 2000. PMID 11114210.
  10. Rowan AJ et al: Aspartame and seizure susceptibility: results of a clinical study in reportedly sensitive individuals; Epilepsia 36(3):270-275, 1995. PMID 7614911.
  11. Camfield et al: Aspartame exacerbates EEG spike-wave discharge in children with generalized absence epilepsy: a double-blind controlled study; Neurology 42(5):1000-1003, 1992. PMID 1579221.
  12. http://epilepsie.nl/diagnose/medicijn, september 2011.
  13. Duncan GE et al: The novel antiepileptic drug lacosamide blocks behavioural and brain metabolic manifestations of seizure activity in the 6 Hz psychomotor seizure model; Epilepsy Res. 67(1-2):81-87, 2005. PMID 16214306.
  14. Swaab D: Wij zijn ons brein – Van baarmoeder tot Alzheimer; Uitgeverij contact, Amsterdam/Antwerpen, 2011. ISBN 978-90-254-3522-6.
  15. Mintzer S et al: Vitmin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine; Epilepsia 47(3):510-515, 2006. PMID 16529614.
  16. Morrell MJ: Folic acid and epilepsy; Epilepsy Curr 2(2):31-34, 2002. PMID 15309159.
  17. Medidb.nl Interacties tussen geneesmiddelen en nutriënten: Foliumzuur/Vitamine B11, september 2011.
  18. Gibberd FB et al; Eur J Clin Pharmacol 19(1):57-60, 1981. PMID 7007061.
  19. Lewis DP et al; Ann Pharmacother 29(7-8):726-735, 1995. PMID 8520091.
  20. Medidb.nl Interacties tussen geneesmiddelen en nutrienten:Vitamine B12, september 2011.
  21. Miller LG: Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions; Arch Intern Med 158:2200-2211, 1998. PMID 9818800.
  22. Harkness R, Bratman S: Mosby’s Handbook of Drug-Herb and Drug-Supplement Interactions; Mosby, St. Louis, 2003.
  23. Wada K et al: An antivitamin B6, 4’-methoxypyridoxine, from the seed of Ginkgo biloba L.; Chem Pharm Bull (Tokyo) 33:3555-3557, 1985. PMID 4085085.
  24. Kupiec T, Raj V: Fatal seizures due to potential herb-drug interactions with Ginkgo biloba; J Anal Toxicol 29:755-758, 2005. PMID 16419414.
  25. He Q et al: Silymarin protects against liver damage in BALB/c mice exposed to fumonisin; Toxicol Sci 80:335-342, 2004. PMID 15103051.
  26. Von Schonfeld J et al: A plant extract with antioxidant and membrane stabilizing properties, protects exocrine pancreas from cyclosporin A toxicity; Cell Mol Life Sci 53:917-920, 1997. PMID 9447243.
  27. Soto C et al: Silymarin induces recovery of pancreatic function after alloxan damage in rats; Life Sci 75:2167-2180, 2004. PMID 15325843.
  28. Sonnenbichler J et al: Stimulatory effects of silibinin and silicristin from the milk thistle Silybum marianum on kidney cells; J Pharmacol Exp Ther 290:1375-1383, 1999. PMID 10454517.
  29. Patrini C et al: Effects of phenytoin on the in vivo kinetics of thiamine and its phosphoesters in rat nervous tissues; Brain Res 628:179-186, 1993. PMID 8313145.
  30. Botez MI et al: Cerebrospinal fluid and blood thiamine concentrations in phenytoin-treated epileptics; Can J Neurol Sci 9:37-39, 1982. PMID 7093823.
  31. Botez MI, Young SN: Effects of anticonvulsant treatment and low levels of folate and thiamine on amine metabolites in cerebrospinal fluid; Brain 114(Pt 1A):333-348, 1991. PMID 1705463.
  32. Botez MI et al: Thiamine and folate treatment of chronic epileptic patients: a controlled study with the Wechsler IQ scale; Epilepsy Res 16:157-163, 1993. PMID 8269914.
  33. Medidb.nl. Interacties tussen geneesmiddelen en nutriënten: Vitamine B2, september 2011.
  34. Bourgeois BF et al: Interactions between primidone, carbamazepine, and nicotinamide; Neurology 32:1122-1126, 1982. PMID 6214728.
  35. Medidb.nl. Interacties tussen geneesmiddelen en nutriënten: Vitamine B6, september 2011
  36. Medidb.nl. Interacties tussen geneesmiddelen en nutriënten: Vitamine D, september 2011.
  37. Keith DA, Gallop PM: Phenytoin, hemorrhage, skeletal defects and vitamin K in the newborn; Med Hypotheses 5:1347-1351, 1979. PMID 537547.
  38. Howe AM et al: Prenatal exposure to phenytoin, facial development, and a possible role for vitamin K; Am J Med Genet 58:238-244, 1995. PMID 8533825.
  39. Keith DA et al: Vitamin K-dependent proteins and anticonvulsant medication; Clin Pharmacol Ther 34:529-532, 1983. PMID 6604612.
  40. Cornelissen M et al: Increased incidence of neonatal vitamin K deficiency resulting from maternal anticonvulsant therapy; Am J Obstet Gynecol 168:923-928, 1993. PMID 8456903.
  41. Kaaja E et al: Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate; Neurology 58:549-553, 2002. PMID 11865131.
  42. Hey E: Effect of maternal anticonvulsant treatment on neonatal blood coagulation; Arch Dis Child Fetal Neonatal Ed 81:F208-F210, 1999. PMID 10525026.
  43. Andon VR, Gupta RK: An experimental evaluation of anticonvulsant activity of Vitex negundo; Indian J Physiol Pharmacol 49:199-205, 2005. PMID 16170989.
  44. Gupta RK, Tandon VR: Antinociceptive activity of Vitex negundo Linn leaf extract; Indian J Physiol Pharmacol 49:163-170, 2005. PMID 16170984.
  45. Skyles AJ, Sweet BV: Alternative therapies. Wormwood; Am J Health Syst Pharm 61:239-242, 2004. PMID 14986553.
  46. Wijnhoven M, Van den Aarsen B: Dictaat SOE nascholing interactie en kwaliteit van voeding en suppletie; p.21, 25 november 2011.
  47. Sullivan C et al: Seizures and natural vitamin E; Med J Aus 152:613-614, 1990. PMID 2348792.
  48. Ogunmekan AO et al; Epilepsia 30(1):84-89, 1989. PMID 2643513.
  49. Raju GB et al; Epilepsia 35:368-372, 1994. PMID 8156959.
  50. Yamamoto N et al: Alpha-tocopheryl-L-ascorbate-2-O-phosphate diester, a hydroxyl radical scavenger; Pathophysiology 8(3):205-214, 2002. PMID 12039653.
  51. McKiernan J et al; Clin Pediatr (Phila) 20(3):208-211, 1981. PMID 7009019.
  52. Hansson O, Hagberg B: Effect of pyridoxine treatment in children with epilepsy; Acta Soc Med Ups 73:35-43, 1968. PMID 5677556.
  53. Nakagawa E et al: Efficacy of pyridoxal phosphate in treating an adult with intractable status epilepticus; Neurology 48:1468-1469, 1997. PMID 9153499.
  54. Jiao FY et al: Randomized, controlled trial of high-dose intravenous pyridoxine in the treatment of recurrent seizures in children; Pediatr Neurol 17:54-57, 1997. PMID 9308977.
  55. Fox JT, Tullidge GM: Pyridoxine (vitamin B6) in epilepsy. A clinical trial; Lancet 2:345, 1946. PMID 20997253.
  56. Heeley AF, Piesowicz AT, McCubbing DG: The biochemical and clinical effect of pyridoxine in children with brain disorders; Clin Sci 35:381-389, 1968. PMID 5721240.
  57. Fois A, Borgheresi S, Luti L: Frequency of relative pyridoxine dependency in epileptic children; Helv Paediatr Acta 21:486-492, 1966. PMID 5991806.
  58. Arnold JD et al: Primary hypomagnesaemia: case report; Aust Paediatr J 19:45-46, 1983. PMID 6870701.
  59. Arnold JD et al: Primary hypomagnesaemia: case report. Aust paediatr J 19:45-46, 1983. PMID 6870701.
  60. Nuytten D et al: Magnesium deficiency as a cause of acute intractable seizures; J Neurol 238:262-264, 1991. PMID 1919610.
  61. http://epilepsie.nl/diagnose/ketogeen, september 2011.
  62. Ramaratnam S et al: Psychological treatment fot epilepsy; Cochrane Database Syst Rev. 2001;(4):CD002029. PMID 11687134.
  63. Ramaratnam S, Sridharan K: Yoga for epilepsy; Cochrane Database Syst Rev. 2000;(3):CD001524. PMID 10908505.

Terug naar overzicht